325 related articles for article (PubMed ID: 27473816)
21. Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy.
Bagley AF; Ye R; Garden AS; Gunn GB; Rosenthal DI; Fuller CD; Morrison WH; Phan J; Sturgis EM; Ferrarotto R; Wu R; Liu AY; Frank SJ
Radiother Oncol; 2020 Jan; 142():133-139. PubMed ID: 31431373
[TBL] [Abstract][Full Text] [Related]
22. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
23. Impact of Oral Cavity Dosimetry on Patient Reported Xerostomia and Dysgeusia in the Setting of Deintensified Chemoradiotherapy.
Fried DV; Das SK; Shen C; Marks LB; Chera BS
Adv Radiat Oncol; 2022; 7(4):100952. PubMed ID: 35814858
[TBL] [Abstract][Full Text] [Related]
24. Treatment-related dysgeusia in head and neck cancer patients.
Irune E; Dwivedi RC; Nutting CM; Harrington KJ
Cancer Treat Rev; 2014 Oct; 40(9):1106-17. PubMed ID: 25064135
[TBL] [Abstract][Full Text] [Related]
25. Survival and quality of life in oropharyngeal cancer patients treated with primary chemoradiation after salivary gland transfer.
Morand GB; Madana J; Da Silva SD; Roskies M; Sultanem K; Black MJ; Mlynarek AM; Hier MP
J Laryngol Otol; 2016 Aug; 130(8):755-62. PubMed ID: 27339712
[TBL] [Abstract][Full Text] [Related]
26. The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer.
Dirix P; Nuyts S; Vander Poorten V; Delaere P; Van den Bogaert W
Support Care Cancer; 2008 Feb; 16(2):171-9. PubMed ID: 17618467
[TBL] [Abstract][Full Text] [Related]
27. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
28. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
[TBL] [Abstract][Full Text] [Related]
29. The eating experience in long-term survivors of head and neck cancer: a mixed-methods study.
Ganzer H; Rothpletz-Puglia P; Byham-Gray L; Murphy BA; Touger-Decker R
Support Care Cancer; 2015 Nov; 23(11):3257-68. PubMed ID: 25851804
[TBL] [Abstract][Full Text] [Related]
30. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
31. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
[TBL] [Abstract][Full Text] [Related]
32. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
[TBL] [Abstract][Full Text] [Related]
33. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
[TBL] [Abstract][Full Text] [Related]
34. Prospective phase II study of the efficacy of transcutaneous electrical nerve stimulation in post-radiation patients.
Vijayan A; Asha ML; Babu S; Chakraborty S
Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):743-7. PubMed ID: 25262845
[TBL] [Abstract][Full Text] [Related]
35. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
Cao J; Zhang X; Jiang B; Chen J; Wang X; Wang L; Sahoo N; Zhu XR; Ye R; Blanchard P; Garden AS; Fuller CD; Gunn GB; Frank SJ
Radiother Oncol; 2021 Jul; 160():32-39. PubMed ID: 33839202
[TBL] [Abstract][Full Text] [Related]
37. Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.
Hegde JV; Shaverdian N; Daly ME; Felix C; Wong DL; Rosove MH; Garst JH; Wang PC; Veruttipong D; Rao S; Fragoso RC; Riess JW; Steinberg ML; Chen AM
Cancer; 2018 Feb; 124(3):521-529. PubMed ID: 29044458
[TBL] [Abstract][Full Text] [Related]
38. Xerostomia in patients treated for oropharyngeal carcinoma: comparing linear accelerator-based intensity-modulated radiation therapy with helical tomotherapy.
Fortin I; Fortin B; Lambert L; Clavel S; Alizadeh M; Filion EJ; Soulières D; Bélair M; Guertin L; Nguyen-Tan PF
Head Neck; 2014 Sep; 36(9):1343-8. PubMed ID: 24038408
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Worden FP; Feng M; Moyer JS; Prince ME; Carey TE; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
J Clin Oncol; 2010 Jun; 28(16):2732-8. PubMed ID: 20421546
[TBL] [Abstract][Full Text] [Related]
40. Oral complications of head and neck radiotherapy: prevalence and management.
Germano F; Melone P; Testi D; Arcuri L; Marmiroli L; Petrone A; Arcuri C
Minerva Stomatol; 2015 Aug; 64(4):189-202. PubMed ID: 25937580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
